0001209191-12-018870.txt : 20120319
0001209191-12-018870.hdr.sgml : 20120319
20120319104552
ACCESSION NUMBER: 0001209191-12-018870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120316
FILED AS OF DATE: 20120319
DATE AS OF CHANGE: 20120319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LUNDAHL SCOTT L
CENTRAL INDEX KEY: 0001205850
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31533
FILM NUMBER: 12699504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DUSA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000879993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223103129
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 UPTON DRIVE
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 9786577500
MAIL ADDRESS:
STREET 1: 25 UPTON DRIVE
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: DEPRENYL USA INC / NJ
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-03-16
0
0000879993
DUSA PHARMACEUTICALS INC
DUSA
0001205850
LUNDAHL SCOTT L
C/O DUSA PHARMACEUTICALS, INC.
25 UPTON DRIVE
WILMINGTON
MA
01887
0
1
0
0
VP, Regulatory Affairs & IP
Common Stock
2012-03-16
4
M
0
17500
1.60
A
228586
D
Common Stock
2012-03-16
4
S
0
7976
5.75
D
220610
D
Common Stock
2012-03-16
4
S
0
1900
5.76
D
218710
D
Common Stock
2012-03-16
4
S
0
5224
5.80
D
213486
D
Common Stock
2012-03-16
4
S
0
800
5.81
D
212686
D
Common Stock
2012-03-16
4
S
0
1600
5.84
D
211086
D
Non-Qualified Stock Option
1.60
2012-03-16
4
M
0
17500
0.00
D
2007-03-13
2013-03-13
common stock
17500
0
D
Includes Stock Awards which vest at the rate of one-quarter of the total grant on each of the first, second, third and fourth anniversaries of the date of the grant.
/s/ Nanette W. Mantell,
Attorney-In-Fact for Scott L. Lundahl
2012-03-19